Venlo, the Netherlands, 13 November 2018 - SHOP APOTHEKE EUROPE N.V., the leading online pharmacy in continental Europe, has amended its forecast for the 2018 financial year. Reasons are among others the currently price-intensive competitive environment in Germany. In addition, the planned process improvements in the second half of the year will probably not offset the negative effects that impacted earnings during the first six months of the year. Taking into account the changed competitive environment and opportunities arising from the current market consolidation, SHOP APOTHEKE EUROPE will further push organic growth from 2019 onwards and intends to increase its marketing expenses in 2018.
 
Under consideration of the business expectations in the current market environment, the Management Board is confident to achieve the recently increased sales forecast of EUR 540 million to EUR 570 million. However, the adjusted EBITDA margin is expected to be up to -2% (previous forecast: -0.5%).
 
SHOP APOTHEKE EUROPE will publish the complete financial figures for the first nine months of 2018 on 14 November 2018.



Contact:
rikutis consulting
Thomas Schnorrenberg
Cel: +49 151 46 53 13 17
E-Mail: presse@shop-apotheke.com